Fresenius Medical Care
Fresenius Medical Care, a leading global provider of products and services for individuals with renal diseases, is headquartered in the United States. Founded in 1996, the company has established a strong presence in North America, Europe, and Asia, focusing on dialysis services and the manufacture of dialysis equipment. With a commitment to innovation, Fresenius Medical Care offers a comprehensive range of products, including dialysis machines and consumables, which are distinguished by their advanced technology and patient-centric design. The company is recognised for its significant market position, serving millions of patients worldwide and achieving notable milestones in improving patient outcomes. As a key player in the healthcare industry, Fresenius Medical Care continues to lead in the development of integrated care solutions, enhancing the quality of life for those affected by chronic kidney disease.
DitchCarbon Score
How does Fresenius Medical Care's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fresenius Medical Care's score of 24 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Fresenius Medical Care's reported carbon emissions
In 2023, Fresenius Medical Care reported total carbon emissions of approximately 3,088,000,000 kg CO2e, with emissions distributed across various scopes: 260,800,000 kg CO2e (Scope 1), 395,800,000 kg CO2e (Scope 2), and a significant 3,084,000,000 kg CO2e (Scope 3). This data highlights the company's substantial carbon footprint, particularly in Scope 3 emissions, which often represent the largest share of total emissions for many organisations. Over the years, the company has shown a trend in its emissions data. For instance, in 2022, total emissions were about 731,300,000 kg CO2e from Scope 1 and 2 combined, while in 2021, this figure was approximately 765,500,000 kg CO2e. The emissions from Scope 1 and 2 have fluctuated, with Scope 1 emissions increasing from 218,700,000 kg CO2e in 2018 to 260,800,000 kg CO2e in 2023. Fresenius Medical Care has committed to achieving net-zero emissions by 2050, as part of its long-term climate strategy. This commitment encompasses all scopes of emissions, reflecting a comprehensive approach to sustainability. The company is actively working towards this goal, having established a near-term target status of "Committed" with the Science Based Targets initiative (SBTi). Overall, Fresenius Medical Care's climate commitments and emissions data underscore its recognition of the importance of addressing climate change within the healthcare sector, aiming for significant reductions in its carbon footprint over the coming decades.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 218,700,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 557,200,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fresenius Medical Care is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
